Donald Notman | Chief Financial Officer |
Antony Mattessich | President & Chief Executive Officer |
Michael Goldstein | Chief Medical Officer |
Joe Catanzaro | Piper Sandler |
Jon Wolleben | JMP Securities |
Dane Leone | Raymond James |
Yi Chen | H.C. Wainwright |
Anita Dushyanth | Berenberg Capital |
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix Fourth Quarter and Year End 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. It is now my pleasure to turn the call over to Donald Notman, Chief Financial Officer of Ocular Therapeutics.